{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:29:28Z","timestamp":1787016568836,"version":"build-2736575974"},"reference-count":343,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Microbiol Rev"],"published-print":{"date-parts":[[2025,3,13]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n                  <jats:p>More than 40 types of sexually transmitted human papillomavirus (HPV) infect the oropharyngeal and anogenital mucosa\u2014high-risk types are associated with precancerous and cancerous lesions of the cervix, vagina, vulva, penis, anus, and oropharynx, and low-risk types cause non-malignant disease, such as anogenital warts. Though most HPV infections resolve spontaneously, immunodeficiencies may result in persistent infection and increased risk of HPV-related sequelae. The mechanism by which HPV results in malignant transformation is multifaceted, involving interactions with numerous cellular pathways, the host immune system, and potentially the host microbiome. Vaccination against HPV is highly efficacious in the prevention of infection and related sequelae, and there now exist several approved formulations that protect against both high- and low-risk types. Despite the advent of vaccination, early detection and treatment of cervical and anal precancerous lesions continues to be integral to secondary prevention\u2014molecular HPV testing, cytology, and tissue biopsy allow for triaging of patients, after which appropriate treatment with close follow-up can avert cancer development.<\/jats:p>","DOI":"10.1128\/cmr.00085-23","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T09:00:26Z","timestamp":1739523626000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":12,"title":["Sexually transmitted human papillomavirus and related sequelae"],"prefix":"10.1128","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9595-8163","authenticated-orcid":true,"given":"Wyatt","family":"Hanft","sequence":"first","affiliation":[{"name":"University of California, San Francisco","place":["San Francisco, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Stankiewicz Karita","sequence":"additional","affiliation":[{"name":"University of California, San Francisco","place":["San Francisco, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikka","family":"Khorsandi","sequence":"additional","affiliation":[{"name":"University of California, San Francisco","place":["San Francisco, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Vohra","sequence":"additional","affiliation":[{"name":"University of California, San Francisco","place":["San Francisco, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalyn","family":"Plotzker","sequence":"additional","affiliation":[{"name":"University of California, San Francisco","place":["San Francisco, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000193"},{"key":"e_1_3_1_3_2","unstructured":"PaVE: the papillomavirus episteme. 2024. Available from: https:\/\/pave.niaid.nih.gov"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2014.12.028"},{"key":"e_1_3_1_5_2","series-title":"IARC monographs on the evaluation of carcinogenic risks to humans","volume-title":"Human papillomaviruses","year":"2011","unstructured":"Human papillomaviruses. 2011. IARC monographs on the evaluation of carcinogenic risks to humans. IARC, Lyon, France."},{"key":"e_1_3_1_6_2","first-page":"1","article-title":"Biological agents. Volume 100 B. A review of human carcinogens","volume":"100","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","year":"2012","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 2012. Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum 100:1\u2013441.","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00013-15"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2012.10.024"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25110"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab603"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiq021"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-2843"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25628"},{"key":"e_1_3_1_14_2","first-page":"677","article-title":"Relationship between smoking, HPV infection, and risk of cervical cancer","volume":"36","author":"Mzarico E","year":"2015","unstructured":"Mzarico E, G\u00f3mez-Roig MD, Guirado L, Lorente N, Gonzalez-Bosquet E. 2015. Relationship between smoking, HPV infection, and risk of cervical cancer. Eur J Gynaecol Oncol 36:677\u2013680.","journal-title":"Eur J Gynaecol Oncol"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09842-6"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000357907"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000001356"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30716"},{"key":"e_1_3_1_19_2","unstructured":"Cancers attibutable to infections. 2024. International Agency for Research on Cancer"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1086\/657321"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(07)70158-5"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01097-3"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(23)00305-4"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-011-2155-8"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30298-3"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02109-2"},{"key":"e_1_3_1_28_2","unstructured":"U.S. Cancer Statistics Working Group. 2023. US Cancer statistics data visualizations tool based on 2022 submission data (1999-2020): US Department of Health and Human Services Centers for Disease Control and Prevention and National Cancer Institute. Centers for Disease Control and Prevention and National Cancer Institute"},{"key":"e_1_3_1_29_2","unstructured":"U.S. Cancer Statistics Working Group. 2022. U.S. Cancer statistics data visualizations tool based on 2021 submission data (1999-2019)"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30459-9"},{"key":"e_1_3_1_31_2","unstructured":"Anal cancer incidence in 2022. Available from: https:\/\/gco.iarc.fr\/today\/en\/dataviz\/tables?mode=population&sexes=1&cancers=10"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34269"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33185"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvr.2022.200245"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2011.03.009"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/hed.24442"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30588"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyp350"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34387"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.4596"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912217"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.06.033"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14020389"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-39"},{"key":"e_1_3_1_46_2","unstructured":"Hall E Wodi A Hamborsky J Morelli V Schillie S. 2021. Epidemiology and prevention of vaccine-preventable diseases. US Department of Health and Human Services Centers for Disease Control and Prevention"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1159\/000355952"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2018\/e486s"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.3390\/v13101892"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094943"},{"key":"e_1_3_1_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2016.11.005"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2013.07.008"},{"key":"e_1_3_1_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/nsb0597-413"},{"key":"e_1_3_1_54_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.6.3531-3541.2003"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01505-22"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1071\/SH15089"},{"key":"e_1_3_1_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1598"},{"key":"e_1_3_1_58_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.3.1565-1570.2001"},{"key":"e_1_3_1_59_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a004952"},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00998-07"},{"key":"e_1_3_1_61_2","doi-asserted-by":"publisher","DOI":"10.3390\/v6124856"},{"key":"e_1_3_1_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2005.11.025"},{"key":"e_1_3_1_63_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.77.24.13125-13135.2003"},{"key":"e_1_3_1_64_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.114.3.585"},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2010.04.007"},{"key":"e_1_3_1_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2013.10.034"},{"key":"e_1_3_1_67_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043519"},{"key":"e_1_3_1_68_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003313"},{"key":"e_1_3_1_69_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002519"},{"key":"e_1_3_1_70_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002657"},{"key":"e_1_3_1_71_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M208691200"},{"key":"e_1_3_1_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1462-5822.2010.01515.x"},{"key":"e_1_3_1_73_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00980-12"},{"key":"e_1_3_1_74_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2001.1493"},{"key":"e_1_3_1_75_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0854.2011.01320.x"},{"key":"e_1_3_1_76_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1302164110"},{"key":"e_1_3_1_77_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01499-15"},{"key":"e_1_3_1_78_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01081-10"},{"key":"e_1_3_1_79_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006308"},{"key":"e_1_3_1_80_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1600638113"},{"key":"e_1_3_1_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2011.03.019"},{"key":"e_1_3_1_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2013.07.020"},{"key":"e_1_3_1_83_2","doi-asserted-by":"publisher","DOI":"10.1111\/tra.12378"},{"key":"e_1_3_1_84_2","doi-asserted-by":"publisher","DOI":"10.3390\/v10060321"},{"key":"e_1_3_1_85_2","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.1822"},{"key":"e_1_3_1_86_2","doi-asserted-by":"publisher","DOI":"10.2174\/1874357901206010190"},{"key":"e_1_3_1_87_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.4110"},{"key":"e_1_3_1_88_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202684109"},{"key":"e_1_3_1_89_2","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2015.54"},{"key":"e_1_3_1_90_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.10178"},{"key":"e_1_3_1_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90384-3"},{"key":"e_1_3_1_92_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210810"},{"key":"e_1_3_1_93_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02004-10"},{"key":"e_1_3_1_94_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00605-09"},{"key":"e_1_3_1_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2013.08.016"},{"key":"e_1_3_1_96_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-05-0778"},{"key":"e_1_3_1_97_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.68.7.4262-4273.1994"},{"key":"e_1_3_1_98_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2696"},{"key":"e_1_3_1_99_2","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.01227"},{"key":"e_1_3_1_100_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1989.tb08594.x"},{"key":"e_1_3_1_101_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00881-07"},{"key":"e_1_3_1_102_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0510012103"},{"key":"e_1_3_1_103_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1116776109"},{"key":"e_1_3_1_104_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02172-12"},{"key":"e_1_3_1_105_2","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.001540"},{"key":"e_1_3_1_106_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20558"},{"key":"e_1_3_1_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2010.07.044"},{"key":"e_1_3_1_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0042-6822(03)00103-X"},{"key":"e_1_3_1_109_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01053-10"},{"key":"e_1_3_1_110_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210798"},{"key":"e_1_3_1_111_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01582-19"},{"key":"e_1_3_1_112_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.05279-11"},{"key":"e_1_3_1_113_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.12.13.2061"},{"key":"e_1_3_1_114_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1999.9771"},{"key":"e_1_3_1_115_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.10.6764"},{"key":"e_1_3_1_116_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202960"},{"key":"e_1_3_1_117_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01737-17"},{"key":"e_1_3_1_118_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aab3291"},{"key":"e_1_3_1_119_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20122394"},{"key":"e_1_3_1_120_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.3970"},{"key":"e_1_3_1_121_2","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6627531"},{"key":"e_1_3_1_122_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2013.10.014"},{"key":"e_1_3_1_123_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100293"},{"key":"e_1_3_1_124_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31883"},{"key":"e_1_3_1_125_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature21386"},{"key":"e_1_3_1_126_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-01431-8"},{"key":"e_1_3_1_127_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27628-3"},{"key":"e_1_3_1_128_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu330"},{"key":"e_1_3_1_129_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087173"},{"key":"e_1_3_1_130_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15856-y"},{"key":"e_1_3_1_131_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9710"},{"key":"e_1_3_1_132_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20677"},{"key":"e_1_3_1_133_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-022-01289-3"},{"key":"e_1_3_1_134_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2021.08.413"},{"key":"e_1_3_1_135_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pvr.2017.08.002"},{"key":"e_1_3_1_136_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.05028-11"},{"key":"e_1_3_1_137_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/102.6.768"},{"key":"e_1_3_1_138_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10060837"},{"key":"e_1_3_1_139_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2013.06.003"},{"key":"e_1_3_1_140_2","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e32831ac557"},{"key":"e_1_3_1_141_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1112513"},{"key":"e_1_3_1_142_2","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000554"},{"key":"e_1_3_1_143_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-08-452763"},{"key":"e_1_3_1_144_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-515528"},{"key":"e_1_3_1_145_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-365049"},{"key":"e_1_3_1_146_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905506"},{"key":"e_1_3_1_147_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20141307"},{"key":"e_1_3_1_148_2","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2011.262"},{"key":"e_1_3_1_149_2","doi-asserted-by":"publisher","DOI":"10.1086\/598220"},{"key":"e_1_3_1_150_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32831cc101"},{"key":"e_1_3_1_151_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.03.034"},{"key":"e_1_3_1_152_2","doi-asserted-by":"publisher","DOI":"10.1086\/424466"},{"key":"e_1_3_1_153_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.8.1031"},{"key":"e_1_3_1_154_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.18.1500"},{"key":"e_1_3_1_155_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.3.226"},{"key":"e_1_3_1_156_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis613"},{"key":"e_1_3_1_157_2","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.5.6.2907"},{"key":"e_1_3_1_158_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jncimonographs.a024166"},{"key":"e_1_3_1_159_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2013.08.018"},{"key":"e_1_3_1_160_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000159669.80207.12"},{"key":"e_1_3_1_161_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qco.0000200295.30285.13"},{"key":"e_1_3_1_162_2","doi-asserted-by":"publisher","DOI":"10.1177\/135965350400900117"},{"key":"e_1_3_1_163_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000186382.81130.ba"},{"key":"e_1_3_1_164_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2024.107927"},{"key":"e_1_3_1_165_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa781"},{"key":"e_1_3_1_166_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003378"},{"key":"e_1_3_1_167_2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800810313"},{"key":"e_1_3_1_168_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12472"},{"key":"e_1_3_1_169_2","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13590"},{"key":"e_1_3_1_170_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14181"},{"key":"e_1_3_1_171_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2017.210"},{"key":"e_1_3_1_172_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2021.08.020"},{"key":"e_1_3_1_173_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.07.005"},{"key":"e_1_3_1_174_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1083-8791(00)70002-4"},{"key":"e_1_3_1_175_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21628"},{"key":"e_1_3_1_176_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24010"},{"key":"e_1_3_1_177_2","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2022-004197"},{"key":"e_1_3_1_178_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2024.105671"},{"key":"e_1_3_1_179_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.04.031"},{"key":"e_1_3_1_180_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.864820"},{"key":"e_1_3_1_181_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.otc.2012.04.001"},{"key":"e_1_3_1_182_2","doi-asserted-by":"publisher","DOI":"10.1155\/2007\/591826"},{"key":"e_1_3_1_183_2","doi-asserted-by":"publisher","DOI":"10.1309\/LM75WGJSVMI7VVEF"},{"key":"e_1_3_1_184_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jasc.2019.06.001"},{"key":"e_1_3_1_185_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa801"},{"key":"e_1_3_1_186_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34199"},{"key":"e_1_3_1_187_2","unstructured":"FDA Roundup: May 17 2024. U.S. Food and Drug Administration."},{"key":"e_1_3_1_188_2","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2020\/44371.13825"},{"key":"e_1_3_1_189_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2021-055303"},{"key":"e_1_3_1_190_2","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2018.0055"},{"key":"e_1_3_1_191_2","doi-asserted-by":"publisher","DOI":"10.3343\/alm.2018.38.2.139"},{"key":"e_1_3_1_192_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030652"},{"key":"e_1_3_1_193_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.20126"},{"key":"e_1_3_1_194_2","volume-title":"Clinical methods: the history, physical, and laboratory examinations","author":"Walker HK","year":"1990","unstructured":"Walker HK, Hall WD, Hurst JW. 1990. Clinical methods: the history, physical, and laboratory examinations"},{"key":"e_1_3_1_195_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990625)87:3<105::AID-CNCR2>3.0.CO;2-Z"},{"key":"e_1_3_1_196_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-53905-7"},{"key":"e_1_3_1_197_2","doi-asserted-by":"publisher","DOI":"10.25259\/CMAS_03_16_2021"},{"key":"e_1_3_1_198_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-018-4763-z"},{"key":"e_1_3_1_199_2","doi-asserted-by":"publisher","DOI":"10.1159\/000528931"},{"key":"e_1_3_1_200_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jasc.2023.11.002"},{"key":"e_1_3_1_201_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-11074-5"},{"key":"e_1_3_1_202_2","doi-asserted-by":"publisher","DOI":"10.1159\/000477556"},{"key":"e_1_3_1_203_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34850"},{"key":"e_1_3_1_204_2","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0000000000000525"},{"key":"e_1_3_1_205_2","doi-asserted-by":"publisher","DOI":"10.1159\/000332704"},{"key":"e_1_3_1_206_2","doi-asserted-by":"publisher","DOI":"10.1002\/dc.10033"},{"key":"e_1_3_1_207_2","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2019.34.e16"},{"key":"e_1_3_1_208_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328333ab8e"},{"key":"e_1_3_1_209_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.13174"},{"key":"e_1_3_1_210_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-14881-1_7"},{"key":"e_1_3_1_211_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sxmr.2019.09.005"},{"key":"e_1_3_1_212_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-51257-0"},{"key":"e_1_3_1_213_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.scrs.2017.04.004"},{"key":"e_1_3_1_214_2","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0000000000000256"},{"key":"e_1_3_1_215_2","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0000000000000789"},{"key":"e_1_3_1_216_2","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0b013e31826916c7"},{"key":"e_1_3_1_217_2","volume-title":"Biopsy interpretation of the gastrointestinal tract mucosa","author":"Montgomery EA","year":"2006","unstructured":"Montgomery EA. 2006. Biopsy interpretation of the gastrointestinal tract mucosa. Lippincott Williams & Wilkins."},{"key":"e_1_3_1_218_2","doi-asserted-by":"publisher","DOI":"10.1097\/MOO.0000000000000341"},{"key":"e_1_3_1_219_2","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000960"},{"key":"e_1_3_1_220_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1277480"},{"key":"e_1_3_1_221_2","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.LGT200570"},{"key":"e_1_3_1_222_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.10897"},{"key":"e_1_3_1_223_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.155029"},{"key":"e_1_3_1_224_2","doi-asserted-by":"publisher","DOI":"10.3390\/biology11070956"},{"key":"e_1_3_1_225_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-020-00310-x"},{"key":"e_1_3_1_226_2","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2019-0093-CP"},{"key":"e_1_3_1_227_2","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2021-0426-OA"},{"key":"e_1_3_1_228_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-1702(02)00197-1"},{"key":"e_1_3_1_229_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-200211000-00018"},{"key":"e_1_3_1_230_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3182387abd"},{"key":"e_1_3_1_231_2","unstructured":"World Health Organization. 2020. Global strategy to accelerate the elimination of cervical cancer as a public health problem. World Health Organization."},{"key":"e_1_3_1_232_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020586"},{"key":"e_1_3_1_233_2","unstructured":"Package insert: GARDASIL [Human papillomavirus quadrivalent (types 6 11 16 and 18) vaccine recombinant] suspension for intramuscular injection initial U.S. approval. 2006. US Food and Drug Administration"},{"key":"e_1_3_1_234_2","unstructured":"Human papillomavirus vaccines: WHO position paper December 2022. 2022. World Health Organization"},{"key":"e_1_3_1_235_2","unstructured":"Package insert: CERVARIX [Human papillomavirus bivalent (types 16 and 18) vaccine recombinant] suspension for intramuscular injection initial U.S. Approval. 2009. U.S. Food and Drug Administration"},{"key":"e_1_3_1_236_2","unstructured":"Package insert: GARDASIL9 (Human papillomavirus 9-valent vaccine recombinant) suspension for intramuscular injection initial U.S. approval. 2014. U.S. Food and Drug Administration"},{"key":"e_1_3_1_237_2","unstructured":"Summary of product characteristic: recombinant human papillomavirus bivalent (types 16 18) vaccine. 2022. U.S. Food and Drug Administration"},{"key":"e_1_3_1_238_2","unstructured":"Package insert: Walrinvax HPV 16\/18 vaccine. 2022. Walvax"},{"key":"e_1_3_1_239_2","unstructured":"Summary of product characteristic: CERVAVAC quadrivalent human papillomavirus (serotype 6 11 16 & 18) vaccine recombinant. 2022"},{"key":"e_1_3_1_240_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa621"},{"key":"e_1_3_1_241_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.04.108"},{"key":"e_1_3_1_242_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.12.079"},{"key":"e_1_3_1_243_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00163-y"},{"key":"e_1_3_1_244_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1625644"},{"key":"e_1_3_1_245_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100401"},{"key":"e_1_3_1_246_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaa011"},{"key":"e_1_3_1_247_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061741"},{"key":"e_1_3_1_248_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60946-5"},{"key":"e_1_3_1_249_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70287-X"},{"key":"e_1_3_1_250_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061760"},{"key":"e_1_3_1_251_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-0461"},{"key":"e_1_3_1_252_2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000773"},{"key":"e_1_3_1_253_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2007.02.015"},{"key":"e_1_3_1_254_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909537"},{"key":"e_1_3_1_255_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1405044"},{"key":"e_1_3_1_256_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2209001"},{"key":"e_1_3_1_257_2","unstructured":"Package insert: CERVAVAC quadrivalent human papillomavirus (serotype 6 11 16 & 18) vaccine recombinant. 2022"},{"key":"e_1_3_1_258_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00480-1"},{"key":"e_1_3_1_259_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1917338"},{"key":"e_1_3_1_260_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02178-4"},{"key":"e_1_3_1_261_2","first-page":"591","article-title":"Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013 - United States","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","unstructured":"Centers for Disease Control and Prevention (CDC). 2013. Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013 - United States. MMWR Morb Mortal Wkly Rep 62:591\u2013595.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_1_262_2","unstructured":"Safety of HPV vaccines. 2017. World Health Organization"},{"key":"e_1_3_1_263_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.03.096"},{"key":"e_1_3_1_264_2","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2100056"},{"key":"e_1_3_1_265_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02658-0"},{"key":"e_1_3_1_266_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(22)00306-0"},{"key":"e_1_3_1_267_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.12.078"},{"key":"e_1_3_1_268_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00453-8"},{"key":"e_1_3_1_269_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6832a3"},{"key":"e_1_3_1_270_2","unstructured":"HPV vaccine included in national immunization programme. 2024. World Health Organization"},{"key":"e_1_3_1_271_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101585"},{"key":"e_1_3_1_272_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12329"},{"key":"e_1_3_1_273_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1612296"},{"key":"e_1_3_1_274_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.4340"},{"key":"e_1_3_1_275_2","unstructured":"Cervical cancer elimination initiative. 2024. World Health Organization"},{"key":"e_1_3_1_276_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad055"},{"key":"e_1_3_1_277_2","first-page":"1","article-title":"Human papillomavirus vaccination coverage in children ages 9-17 years: United States, 2022","volume":"495","author":"Villarroel MA","year":"2024","unstructured":"Villarroel MA, Galinsky AM, Lu PJ, Pingali C. 2024. Human papillomavirus vaccination coverage in children ages 9-17 years: United States, 2022. NCHS Data Brief 495:1\u20138.","journal-title":"NCHS Data Brief"},{"key":"e_1_3_1_278_2","unstructured":"Human papillomavirus (HPV) immunisation data. 2024. Available from: https:\/\/www.health.gov.au\/topics\/immunisation\/immunisation-data\/human-papillomavirus-hpv-immunisation-data"},{"key":"e_1_3_1_279_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7234a3"},{"key":"e_1_3_1_280_2","unstructured":"HPV-IMPACT monitoring project. Available from: https:\/\/www.cdc.gov\/ncird\/surveillance\/hpvimpact\/index.html"},{"key":"e_1_3_1_281_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2019.12.003"},{"key":"e_1_3_1_282_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(23)00193-6"},{"key":"e_1_3_1_283_2","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000264"},{"key":"e_1_3_1_284_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21628"},{"key":"e_1_3_1_285_2","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0000000000000614"},{"key":"e_1_3_1_286_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7004a1"},{"key":"e_1_3_1_287_2","unstructured":"Panel on guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. 2024. Available from: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections\/human?view=full"},{"key":"e_1_3_1_288_2","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0000000000000529"},{"key":"e_1_3_1_289_2","unstructured":"Hirsch B Fine SM Vail R McGowan JP Merrick ST Radix A Hoffmann CJ Gonzalez CJ. 2022. Screening for anal dysplasia and cancer in adults with HIV"},{"key":"e_1_3_1_290_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2201048"},{"key":"e_1_3_1_291_2","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0000000000001143"},{"key":"e_1_3_1_292_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djae094"},{"key":"e_1_3_1_293_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-1065"},{"key":"e_1_3_1_294_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16522"},{"key":"e_1_3_1_295_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-020-00357-z"},{"key":"e_1_3_1_296_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18638"},{"key":"e_1_3_1_297_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03796.x"},{"key":"e_1_3_1_298_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-027765"},{"key":"e_1_3_1_299_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.04.012"},{"key":"e_1_3_1_300_2","first-page":"151","article-title":"Liquid nitrogen cryotherapy versus 70% trichloroacetic acid in the treatment of anogenital warts: a randomized controlled trial","volume":"18","author":"Pegah L","year":"2015","unstructured":"Pegah L, Farzaneh M, Ali G, Mohammad Javad Y. 2015. Liquid nitrogen cryotherapy versus 70% trichloroacetic acid in the treatment of anogenital warts: a randomized controlled trial. Iran J Dermatol 18:151\u2013155.","journal-title":"Iran J Dermatol"},{"key":"e_1_3_1_301_2","doi-asserted-by":"publisher","DOI":"10.1177\/09564624241233338"},{"key":"e_1_3_1_302_2","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15384"},{"key":"e_1_3_1_303_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12237317"},{"key":"e_1_3_1_304_2","unstructured":"Intralesional HPV vaccine for condylomata. 2023. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05087849"},{"key":"e_1_3_1_305_2","unstructured":"Effectiveness study of human papilloma virus (HPV) vaccines to prevent recurrence of genital warts (TheraVACCS). 2024. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02750202"},{"key":"e_1_3_1_306_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70103-7"},{"key":"e_1_3_1_307_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-075925"},{"key":"e_1_3_1_308_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2020.01.023"},{"key":"e_1_3_1_309_2","unstructured":"World Health Organization. 2019. WHO guidelines for the use of thermal ablation for cervical pre-cancer lesions"},{"key":"e_1_3_1_310_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001318.pub2"},{"key":"e_1_3_1_311_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00334-5"},{"key":"e_1_3_1_312_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.2683"},{"key":"e_1_3_1_313_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31825bc6e8"},{"key":"e_1_3_1_314_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2022.01.033"},{"key":"e_1_3_1_315_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-3639"},{"key":"e_1_3_1_316_2","unstructured":"Vvax001 cancer vaccine in premalignant cervical lesions - phase II (Vvax). 2023 Available from: https:\/\/clinicaltrials.gov\/study\/NCT06015854"},{"key":"e_1_3_1_317_2","unstructured":"HPV DNA vaccine via electroporation for HPV16 positive cervical neoplasia. 2025 Available from: https:\/\/clinicaltrials.gov\/study\/NCT04131413"},{"key":"e_1_3_1_318_2","unstructured":"NWRD08 DNA plasmid for HPV-16 and\/or HPV-18 related cervical HSIL. 2024 Available from: https:\/\/clinicaltrials.gov\/study\/NCT06276101"},{"key":"e_1_3_1_319_2","volume-title":"International Papillomavirus Conference (IPVC","author":"Einstein BF","year":"2021","unstructured":"Einstein BF, Dallas M, Giffear M, Herring T, Kraynyak K, Marrow M, Bhuyan P, Humeau L. 2021. VGX-3100 for treatment of HPV16\/18 related cervical HSIL: results from a phase 3 study. International Papillomavirus Conference (IPVC."},{"key":"e_1_3_1_320_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1823778"},{"key":"e_1_3_1_321_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-069616"},{"key":"e_1_3_1_322_2","unstructured":"Pembrolizumab (IVIG) for the treatment of cervical intraepithelial neoplasia. 2024 Available from: https:\/\/clinicaltrials.gov\/study\/NCT04712851"},{"key":"e_1_3_1_323_2","unstructured":"Artesunate vaginal inserts for the treatment of cervical intraepithelial neoplasia (CIN2\/3) (ART-CIN_IIB). 2024 Available from: https:\/\/clinicaltrials.gov\/study\/NCT04098744"},{"key":"e_1_3_1_324_2","unstructured":"Topical curcumin for HPV related cervical disease. 2025 Available from: https:\/\/clinicaltrials.gov\/study\/NCT04266275"},{"key":"e_1_3_1_325_2","unstructured":"RX-2 regimen in treating women with cervical squamous intraepithelial neoplasia 3 or squamous vulvar intraepithelial neoplasia 3. 2025 Available from: https:\/\/clinicaltrials.gov\/study\/NCT03267680"},{"key":"e_1_3_1_326_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2017.12.013"},{"key":"e_1_3_1_327_2","unstructured":"Probiotc Lactobacillus crispatus-M247 (Crispact) supplementation in the sterilization of high-risk human papilloma (HPV-HR) viruses. 2024 Available from: https:\/\/clinicaltrials.gov\/study\/NCT06245486"},{"key":"e_1_3_1_328_2","unstructured":"Study of 2LPAPI on the clearance of genital HR-HPV infections. 2024 (PAPION). Available from: https:\/\/clinicaltrials.gov\/study\/NCT04232917"},{"key":"e_1_3_1_329_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-2197.2006.03837.x"},{"key":"e_1_3_1_330_2","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0000000000001180"},{"key":"e_1_3_1_331_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10151-019-01951-w"},{"key":"e_1_3_1_332_2","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0000000000001219"},{"key":"e_1_3_1_333_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-19-0601"},{"key":"e_1_3_1_334_2","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S38217"},{"key":"e_1_3_1_335_2","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12544"},{"key":"e_1_3_1_336_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10151-020-02379-3"},{"key":"e_1_3_1_337_2","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2024.2303021"},{"key":"e_1_3_1_338_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70067-6"},{"key":"e_1_3_1_339_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000226955.02719.26"},{"key":"e_1_3_1_340_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-3361"},{"key":"e_1_3_1_341_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir1036"},{"key":"e_1_3_1_342_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy274"},{"key":"e_1_3_1_343_2","unstructured":"Clinical trial for evaluating the efficacy and safety of electrocoagulation vs topic sinecatechins vs topic cidofovir within the treatment to high-grade anal intraepithelial neoplasia in HIV homosexual males (TreatAIN). 2024 Available from: https:\/\/clinicaltrials.gov\/study\/NCT04055142"},{"key":"e_1_3_1_344_2","unstructured":"Artesunate ointment for the treatment of anal HSIL in HIV-negative participants (ART-AIN IIB-2). 2024 Available from: https:\/\/clinicaltrials.gov\/study\/NCT06206564"}],"container-title":["Clinical Microbiology Reviews"],"original-title":[],"contributor":[{"given":"Quentin","family":"Lepiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"reviewer"}]}],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/cmr.00085-23","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/cmr.00085-23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T09:03:15Z","timestamp":1741856595000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/cmr.00085-23"}},"subtitle":[],"editor":[{"given":"Graeme N.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":343,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3,13]]}},"alternative-id":["10.1128\/cmr.00085-23"],"URL":"https:\/\/doi.org\/10.1128\/cmr.00085-23","relation":{},"ISSN":["0893-8512","1098-6618"],"issn-type":[{"value":"0893-8512","type":"print"},{"value":"1098-6618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"2025-02-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00085-23"}}